{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:47:47Z","timestamp":1791272867517,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T00:00:00Z","timestamp":1329523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10157-012-0609-3","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T08:10:12Z","timestamp":1329466212000},"page":"549-556","source":"Crossref","is-referenced-by-count":85,"title":["Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy"],"prefix":"10.1007","volume":"16","author":[{"given":"Hiroki","family":"Omori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritaka","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyasu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunya","family":"Kaimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Takabatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,18]]},"reference":[{"key":"609_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","volume":"53","author":"M Madero","year":"2009","unstructured":"Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009;53:796\u2013803.","journal-title":"Am J Kidney Dis"},{"key":"609_CR2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1053\/j.ajkd.2006.08.019","volume":"48","author":"ME Suliman","year":"2006","unstructured":"Suliman ME, Johnson RJ, Garcia-Lopez E, Qureshi AR, Molinaei H, Carrero JJ, Heimburger O, Barany P, Axelsson J, Lindholm B, Stenvinkel P. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 2006;48:761\u201371.","journal-title":"Am J Kidney Dis"},{"key":"609_CR3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincon A, Arroyo D, Luno J. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol. 2010;5:1388\u201393.","journal-title":"Clin J Am Soc Nephrol"},{"key":"609_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000127837","volume":"108","author":"LG Sanchez-Lozada","year":"2008","unstructured":"Sanchez-Lozada LG, Tapia E, Soto V, Avila-Casado C, Franco M, Wessale JL, Zhao L, Johnson RJ. Effect of febuxostat on the progression of renal disease in 5\/6 nephrectomy rats with and without hyperuricemia. Nephron Physiol. 2008;108:69\u201378.","journal-title":"Nephron Physiol"},{"key":"609_CR5","doi-asserted-by":"crossref","first-page":"F481","DOI":"10.1152\/ajprenal.00092.2009","volume":"297","author":"T Kosugi","year":"2009","unstructured":"Kosugi T, Nakayama T, Heinig M, Zhang L, Yuzawa Y, Sanchez-Lozada LG, Roncal C, Johnson RJ, Nakagawa T. Effect of lowering uric acid on renal disease in the type 2 diabetic db\/db mice. Am J Physiol Renal Physiol. 2009;297:F481\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"609_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/HJH.0b013e3282f240bf","volume":"26","author":"DB Corry","year":"2008","unstructured":"Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens. 2008;26:269\u201375.","journal-title":"J Hypertens"},{"key":"609_CR7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1046\/j.1523-1755.1999.00612.x","volume":"56","author":"N Kawada","year":"1999","unstructured":"Kawada N, Moriyama T, Ando A, Fukunaga M, Miyata T, Kurokawa K, Imai E, Hori M. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 1999;56:1004\u201313.","journal-title":"Kidney Int"},{"key":"609_CR8","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/HJH.0b013e328337da1d","volume":"28","author":"MA Yu","year":"2010","unstructured":"Yu MA, Sanchez-Lozada LG, Johnson RJ, Kang DH. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010;28:1234\u201342.","journal-title":"J Hypertens"},{"key":"609_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","volume":"312","author":"JM McCord","year":"1985","unstructured":"McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159\u201363.","journal-title":"N Engl J Med"},{"key":"609_CR10","doi-asserted-by":"crossref","first-page":"C584","DOI":"10.1152\/ajpcell.00600.2006","volume":"293","author":"YY Sautin","year":"2007","unstructured":"Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative\/nitrosative stress. Am J Physiol Cell Physiol. 2007;293:C584\u201396.","journal-title":"Am J Physiol Cell Physiol"},{"key":"609_CR11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","volume":"27","author":"U Landmesser","year":"2007","unstructured":"Landmesser U, Spiekermann S, Preuss C, Sorrentino S, Fischer D, Manes C, Mueller M, Drexler H. Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease. Arterioscler Thromb Vasc Biol. 2007;27:943\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"609_CR12","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0022-5347(01)65546-0","volume":"156","author":"MR Young","year":"1996","unstructured":"Young MR, Young IS, Johnston SR, Rowlands BJ. Lipid peroxidation assessment of free radical production following release of obstructive uropathy. J Urol. 1996;156:1828\u201332.","journal-title":"J Urol"},{"key":"609_CR13","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","volume":"76","author":"Y Takano","year":"2005","unstructured":"Takano Y, Hase-Aoki K, Horiuchi H, Zhao L, Kasahara Y, Kondo S, Becker MA. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase. Life Sci. 2005;76:1835\u201347.","journal-title":"Life Sci"},{"key":"609_CR14","first-page":"307","volume":"104","author":"H Horiuchi","year":"1999","unstructured":"Horiuchi H, Ota M, Kobayashi M, Kaneko H, Kasahara Y, Nishimura S, Kondo S, Komoriya K. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase\/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats. Res Commun Mol Pathol Pharmacol. 1999;104:307\u201319.","journal-title":"Res Commun Mol Pathol Pharmacol"},{"key":"609_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0891-5849(89)90068-3","volume":"6","author":"JS Beckman","year":"1989","unstructured":"Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radic Biol Med. 1989;6:607\u201315.","journal-title":"Free Radic Biol Med"},{"key":"609_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2005.10.008","volume":"133","author":"I Mohiuddin","year":"2006","unstructured":"Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C. Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res. 2006;133:143\u20139.","journal-title":"J Surg Res"},{"key":"609_CR17","first-page":"F251","volume":"263","author":"EL Greene","year":"1992","unstructured":"Greene EL, Paller MS. Xanthine oxidase produces O 2 \u2212. in posthypoxic injury of renal epithelial cells. Am J Physiol. 1992;263:F251\u20135.","journal-title":"Am J Physiol"},{"key":"609_CR18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jss.2008.06.018","volume":"155","author":"LM Contrin","year":"2009","unstructured":"Contrin LM, Lobo SM, Navegantes LC, Orrico SP, Queiroz MM, Cury PM, Lira EC, Carta A, Yamamoto AE, Vincent JL. Tyrosine: a possible marker of severe intestinal injury during ischemia. J Surg Res. 2009;155:268\u201372.","journal-title":"J Surg Res"},{"key":"609_CR19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.200707-1019OC","volume":"179","author":"MJ Paul-Clark","year":"2009","unstructured":"Paul-Clark MJ, McMaster SK, Sorrentino R, Sriskandan S, Bailey LK, Moreno L, Ryffel B, Quesniaux VF, Mitchell JA. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med. 2009;179:299\u2013306.","journal-title":"Am J Respir Crit Care Med"},{"key":"609_CR20","first-page":"S232","volume":"63","author":"T Moriyama","year":"1997","unstructured":"Moriyama T, Kawada N, Akagi Y, Ando A, Horio M, Yamauchi A, Nagata K, Imai E, Hori M. TCV-116 inhibits interstitial fibrosis and HSP47 mRNA in rat obstructive nephropathy. Kidney Int Suppl. 1997;63:S232\u20135.","journal-title":"Kidney Int Suppl"},{"key":"609_CR21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1523-1755.2005.00486.x","volume":"68","author":"JL Bascands","year":"2005","unstructured":"Bascands JL, Schanstra JP. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 2005;68:925\u201337.","journal-title":"Kidney Int"},{"key":"609_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCHEARTFAILURE.109.868604","volume":"3","author":"K Ogino","year":"2010","unstructured":"Ogino K, Kato M, Furuse Y, Kinugasa Y, Ishida K, Osaki S, Kinugawa T, Igawa O, Hisatome I, Shigemasa C, Anker SD, Doehner W. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study. Circ Heart Fail. 2010;3:73\u201381.","journal-title":"Circ Heart Fail"},{"key":"609_CR23","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/sj.ki.5001983","volume":"70","author":"S Aslam","year":"2006","unstructured":"Aslam S, Santha T, Leone A, Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int. 2006;70:2109\u201315.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0609-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-012-0609-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-012-0609-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T17:51:34Z","timestamp":1640800294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-012-0609-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,18]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["609"],"URL":"https:\/\/doi.org\/10.1007\/s10157-012-0609-3","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,18]]}}}